MedTrace Logo

Chronic Obstructive Pulmonary Disease in Combination With Atherosclerosis (Clinical and Biochemical Study)

NCT04474717 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 476

Last updated 2023-07-24

No results posted yet for this study

Summary

one-centered, open, non-randomized, controlled clinical trial will focus on a comprehensive study of the clinical, functional and molecular biochemical characteristics of the natural course of COPD in combination with peripheral atherosclerosis

Conditions

Interventions

DIAGNOSTIC_TEST

Breath Condensate Collection

Breath Condensate Collection

DIAGNOSTIC_TEST

clinical examination, spirometry

spirometry

DIAGNOSTIC_TEST

blood monocyte assay

study of blood monocytes in the laboratory of cell technology

Sponsors & Collaborators

  • Ryazan State Medical University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-15
Primary Completion
2023-07-19
Completion
2023-07-19

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04474717 on ClinicalTrials.gov